We acknowledge that GAPSS incorporates both laboratory (e.g., aCL, anti-β2GPI, LAC, aPS/PT) and non-laboratory clinical parameters, including hypertension and dyslipidemia. This evidence concerns the gene APOH and metabolic syndrome.